AMPLIFY: Apixaban in acute VTE; RESPECT "device-in-place" analysis; CV risk and HbA1c; aggressive glucose control in CV surgery patients with T2D

AMPLIFY: Apixaban in acute VTE; RESPECT "device-in-place" analysis; CV risk and HbA1c; aggressive glucose control in CV surgery patients with T2D

Source: Radio TheHeart.org - July 5, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts